Embla Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	928.69	854.89	785.68	718.65	718.67
Revenue Growth (YoY)	8.63%	8.81%	9.33%	-0.00%	14.16%
Cost of Revenue	350.13	320.19	300.11	278.9	263.28
Gross Profit	578.56	534.7	485.57	439.75	455.39
Selling, General & Admin	408	381.12	359.97	338.59	328.03
Research & Development	45.86	40.83	38.14	34.02	31.74
Operating Expenses	453.86	421.95	398.11	372.61	359.76
Operating Income	124.7	112.75	87.46	67.14	95.62
Interest Expense	-19.52	-23.25	-17.96	-11.2	-9.8
Interest & Investment Income	1.52	1.97	3.45	0.78	0.17
Earnings From Equity Investments	6.66	3.34	3.4	0.36	0.4
Currency Exchange Gain (Loss)	-4.97	-4.44	-0.67	2.61	1.12
Other Non Operating Income (Expenses)	-0.45	0.19	0.33	-3.51	-0.87
EBT Excluding Unusual Items	107.94	90.56	76.01	56.17	86.64
Pretax Income	107.94	90.56	76.01	56.17	86.64
Income Tax Expense	24.29	21.6	17.21	12.96	20.98
Earnings From Continuing Operations	83.65	68.96	58.8	43.21	65.66
Minority Interest in Earnings	-0.31	-0.68	-0.41	-0.7	-1.66
Net Income	83.34	68.28	58.39	42.51	63.99
Net Income to Common	83.34	68.28	58.39	42.51	63.99
Net Income Growth	22.05%	16.94%	37.34%	-33.57%	929.84%
Shares Outstanding (Basic)	427	427	420	418	422
Shares Outstanding (Diluted)	427	427	420	418	423
Shares Change (YoY)	0.08%	1.51%	0.60%	-1.17%	0.02%
EPS (Basic)	0.20	0.16	0.14	0.10	0.15
EPS (Diluted)	0.20	0.16	0.14	0.10	0.15
EPS Growth	21.96%	15.20%	36.53%	-32.78%	929.72%
Free Cash Flow	110.55	89.03	65.09	44.22	83.57
Free Cash Flow Per Share	0.26	0.21	0.15	0.11	0.20
Gross Margin	62.30%	62.55%	61.80%	61.19%	63.37%
Operating Margin	13.43%	13.19%	11.13%	9.34%	13.31%
Profit Margin	8.97%	7.99%	7.43%	5.92%	8.91%
Free Cash Flow Margin	11.90%	10.42%	8.29%	6.15%	11.63%
EBITDA	150.14	136.92	108.29	89.45	119.86
EBITDA Margin	16.17%	16.02%	13.78%	12.45%	16.68%
D&A For EBITDA	25.45	24.16	20.83	22.31	24.23
EBIT	124.7	112.75	87.46	67.14	95.62
EBIT Margin	13.43%	13.19%	11.13%	9.34%	13.31%
Effective Tax Rate	22.50%	23.85%	22.64%	23.08%	24.22%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.